Skip to content

Circulatory Levels of Irisin in Response to Acute Resistance Training

Circulatory Levels of Irisin in Response to Acute Resistance Training

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02478658
Enrollment
28
Registered
2015-06-23
Start date
2015-02-28
Completion date
2015-12-31
Last updated
2019-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

irisin, resistance training, physical fitness, Volunteers

Brief summary

Study the circulatory levels of irisin in response to one session of high-intensity resistance training in a group of healthy subjects.

Detailed description

Objective: The purpose of this study is to study the circulating levels of irisin in response to acute high-intensity resistance training in a group of healthy young adults. Sample: The sample will be comprised of adult men and women unpaid volunteers between the ages of 18 and 30. We will recruit 44 participants. Pre- screening assessments: Informed consent, PAR-Q, Medical History and Exercise History will be used to determine health status and prior exercise experience. Menstrual cycle log will be required for female participants. Pre-Intervention assessments (baseline): * Anthropometric measurements and Body Composition: Height, triceps, thigh and calf skinfolds, biceps, thigh, hip, waist, and calf circumferences will be measured. Dual-energy x-ray absorptiometry (DEXA) will be performed to obtain body composition. * Blood-related variables. Baseline glucose, lactate and hematocrit will be obtained from all participants prior to intervention. Lactate and Hematocrit will be obtained pre-intervention and post-intervention, and within 1 min post workout. Irisin will be obtained from blood samples at baseline, during and after the training session. Irisin will be measured via a commercial enzyme-linked immunosorbent assay. * Cardiopulmonary and Strength Fitness Testing. Cardiopulmonary fitness will be determined via maximum oxygen consumption testing. One maximum repetition (1-RM) will be used to assess the muscular fitness. * Dietary Controls. Each participant will complete the Food Preference Questionnaire. In addition, the Automated Self-Administered 24-hour Recall (ASA24) will be collected for the day prior to the session. * Familiarization. Participant will be instructed on the muscle conditioning techniques used for strength training so that the techniques can be mastered. The rate of perceived exertion (RPE) scale will also be used for familiarization during these sessions. * Spontaneous Physical Activity: Daily activity level for 7 days will be collected. Intervention: Resistance training will consist on a circuit training of 3 sets of 7 exercises focused on major muscle groups. Ten repetitions on each circuit at 70% of the maximum capacity will be performed. Acute intervention will consist of one session. Blood will be collected pre-session, at 45 min during the session, and immediately after the acute intervention exposure (post-session).

Interventions

OTHERexercise training

high-intensity resistance training

Sponsors

Texas Tech University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Participants between 18 and 30 years old * Males and Females * Healthy

Exclusion criteria

* Participants with known health problems such as cardiovascular, pulmonary or metabolic disease will be excluded. * Pregnant females will be excluded from the study. * Any adults found taking medications that affect endocrine or cardiovascular function will also be excluded from the study. * Individuals found to be less than 110 pounds will also be excluded due to the collection of blood during this study. * Participants that exercise more than three times per week or strength train more than twice per week will be excluded. * Individuals that have poor venous access or have expressed a fear of needles or having blood taken will also be excluded. * Cigarette smoking (current or those who quit within the previous 6 months * Hypertension * Overweight and obese * Pre-diabetics

Design outcomes

Primary

MeasureTime frameDescription
Serum irisin levels1 dayChanges in irisin levels baseline, 45 min (during the training session), and post-training session

Secondary

MeasureTime frameDescription
Lactate levels1 dayIntensity of exercise at the end of the session (post-training session)
Physical Fitness levels as measured by 1 RM (repetition maximum) and Cardio-respiratory maximal test1dayPhysical Fitness levels at baseline prior to the training session
Blood Glucose levels1 session (1 day)Blood Glucose levels at baseline prior to the training session
Body composition assessment, as measured by DEXA and anthropometry1 dayBody composition at baseline prior to the training session
Hematocrit concentration1 dayHematocrit levels at baseline and post-training session
Physical Activity assessment, as measured by Accelerometry.1 weekQuantification of baseline Physical Activity levels at baseline prior to the training session
Diet assessment: 24 hour recall and Food Preference Questionnaire1dayDietary habits at baseline prior to the training session

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026